Zoetis Inc. (NYSE:ZTS) Stock Holdings Lessened by Douglass Winthrop Advisors LLC

Douglass Winthrop Advisors LLC reduced its position in shares of Zoetis Inc. (NYSE:ZTSFree Report) by 0.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 537,007 shares of the company’s stock after selling 1,606 shares during the quarter. Zoetis accounts for 2.4% of Douglass Winthrop Advisors LLC’s investment portfolio, making the stock its 18th biggest holding. Douglass Winthrop Advisors LLC’s holdings in Zoetis were worth $105,989,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ZTS. Blue Bell Private Wealth Management LLC grew its holdings in shares of Zoetis by 222.5% during the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock valued at $25,000 after acquiring an additional 89 shares in the last quarter. Independence Bank of Kentucky boosted its holdings in Zoetis by 371.4% in the fourth quarter. Independence Bank of Kentucky now owns 165 shares of the company’s stock worth $33,000 after purchasing an additional 130 shares in the last quarter. Private Wealth Management Group LLC bought a new stake in Zoetis in the fourth quarter worth $33,000. Ramirez Asset Management Inc. bought a new stake in Zoetis in the third quarter worth $35,000. Finally, Gladius Capital Management LP bought a new stake in Zoetis in the fourth quarter worth $40,000. 92.80% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. HSBC decreased their price objective on shares of Zoetis from $230.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Stifel Nicolaus decreased their price objective on shares of Zoetis from $195.00 to $180.00 and set a “buy” rating for the company in a report on Tuesday, April 30th. The Goldman Sachs Group decreased their price target on shares of Zoetis from $223.00 to $196.00 and set a “buy” rating for the company in a report on Monday, May 6th. StockNews.com cut shares of Zoetis from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Finally, Piper Sandler restated an “overweight” rating and set a $195.00 price target (down from $220.00) on shares of Zoetis in a report on Tuesday, April 16th. Eight equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $211.75.

Get Our Latest Analysis on ZTS

Zoetis Stock Performance

Shares of ZTS traded down $0.83 during trading hours on Monday, reaching $170.07. 1,893,800 shares of the company traded hands, compared to its average volume of 3,052,681. The stock’s fifty day moving average is $164.10 and its 200 day moving average is $179.76. The stock has a market cap of $77.60 billion, a P/E ratio of 32.77, a price-to-earnings-growth ratio of 2.64 and a beta of 0.86. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.94 and a current ratio of 3.33. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $201.92.

Zoetis (NYSE:ZTSGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $1.38 EPS for the quarter, beating analysts’ consensus estimates of $1.34 by $0.04. The business had revenue of $2.19 billion during the quarter, compared to analyst estimates of $2.14 billion. Zoetis had a net margin of 27.38% and a return on equity of 50.34%. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.31 earnings per share. Equities research analysts anticipate that Zoetis Inc. will post 5.76 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 4th. Stockholders of record on Thursday, July 18th will be given a dividend of $0.432 per share. This represents a $1.73 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date is Thursday, July 18th. Zoetis’s dividend payout ratio is currently 33.33%.

Insider Activity

In other news, EVP Roxanne Lagano sold 923 shares of the company’s stock in a transaction dated Thursday, April 18th. The shares were sold at an average price of $151.17, for a total transaction of $139,529.91. Following the completion of the transaction, the executive vice president now owns 14,800 shares of the company’s stock, valued at $2,237,316. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.16% of the stock is owned by company insiders.

About Zoetis

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

See Also

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTSFree Report).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.